PaxMedica, Inc. Common Stock
PXMD
PXMD was delisted on the 1st of May, 2024.
8 hedge funds and large institutions have $165K invested in PaxMedica, Inc. Common Stock in 2023 Q2 according to their latest regulatory filings, with 2 funds opening new positions, 2 increasing their positions, 1 reducing their positions, and 4 closing their positions.
100% more repeat investments, than reductions
Existing positions increased: 2 | Existing positions reduced: 1
20% less funds holding
Funds holding: 10 → 8 (-2)
46% less capital invested
Capital invested by funds: $308K → $165K (-$142K)
50% less first-time investments, than exits
New positions opened: 2 | Existing positions closed: 4
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Citadel Advisors
Miami,
Florida
|
+$99.5K |
| 2 |
HF
HRT Financial
New York
|
+$37.5K |
| 3 |
TRCT
Tower Research Capital (TRC)
New York
|
+$5.39K |
| 4 |
Wells Fargo
San Francisco,
California
|
+$25 |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
UBS Group
Zurich,
Switzerland
|
-$33.9K |
| 2 |
Susquehanna International Group
Bala Cynwyd,
Pennsylvania
|
-$26.1K |
| 3 |
VF
Virtu Financial
New York
|
-$24K |
| 4 |
Bank of America
Charlotte,
North Carolina
|
-$5.37K |
| 5 |
Osaic Holdings
Scottsdale,
Arizona
|
-$1.91K |
PXMD Hedge Fund Activity: Q2 2023 in Review
8 of the 6,369 institutional investors tracked by Wall St. Rank reported a position in PaxMedica, Inc. Common Stock (PXMD) for Q2 2023, worth a combined $165K — down 46% from $308K a quarter earlier.
Sellers outnumbered buyers: 4 funds closed out of PXMD and 2 opened new positions — a net loss of 2 holders — while 1 trimmed existing stakes and 2 added.
The largest buyer was Citadel Advisors, opening a new position worth an estimated $99.5K. The largest seller was UBS Group, exiting entirely with an estimated $33.9K sold.
- 8 institutional investors held PaxMedica, Inc. Common Stock (PXMD) as of Q2 2023, down from 10 in Q1 2023.
- Funds reported $165K of PaxMedica, Inc. Common Stock stock for Q2 2023, down 46% quarter-over-quarter.
- 2 funds opened new PaxMedica, Inc. Common Stock positions in Q2 2023 and 4 closed out, a net change of -2 holders.
- The largest PaxMedica, Inc. Common Stock buyer in Q2 2023 was Citadel Advisors, an estimated $99.5K added.
- The largest PaxMedica, Inc. Common Stock seller in Q2 2023 was UBS Group, an estimated $33.9K sold.
Based on aggregated 13F filings for Q2 2023.